L. Jara-Palomares, S. Marin-Romero, M. Asensio-Cruz, T. Elías-Hernández, Rocío Ortega-Rivera, R. Otero-Candelera, E. Montero-Romero, Rodrigo Tallon-Aguilar, Maria Dolores Ucero-Leon, Manuel Arellano-Ceballos, M. Espada, C. Fernandez-Garcia, J. Sánchez-Díaz, V. Sánchez-López, E. Arellano-Orden, M. Ferrer-Galván, Stefano Barco
{"title":"在接受低分子肝素治疗的患者中,抗Xa因子水平与静脉血栓栓塞复发和临床相关出血相关","authors":"L. Jara-Palomares, S. Marin-Romero, M. Asensio-Cruz, T. Elías-Hernández, Rocío Ortega-Rivera, R. Otero-Candelera, E. Montero-Romero, Rodrigo Tallon-Aguilar, Maria Dolores Ucero-Leon, Manuel Arellano-Ceballos, M. Espada, C. Fernandez-Garcia, J. Sánchez-Díaz, V. Sánchez-López, E. Arellano-Orden, M. Ferrer-Galván, Stefano Barco","doi":"10.1183/13993003.congress-2019.pa1460","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":20797,"journal":{"name":"Pulmonary embolism","volume":"37 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Anti-Factor Xa levels correlate with recurrent venous thromboembolism and clinically relevant bleeding in patients receiving low-molecular-weight heparin\",\"authors\":\"L. Jara-Palomares, S. Marin-Romero, M. Asensio-Cruz, T. Elías-Hernández, Rocío Ortega-Rivera, R. Otero-Candelera, E. Montero-Romero, Rodrigo Tallon-Aguilar, Maria Dolores Ucero-Leon, Manuel Arellano-Ceballos, M. Espada, C. Fernandez-Garcia, J. Sánchez-Díaz, V. Sánchez-López, E. Arellano-Orden, M. Ferrer-Galván, Stefano Barco\",\"doi\":\"10.1183/13993003.congress-2019.pa1460\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":20797,\"journal\":{\"name\":\"Pulmonary embolism\",\"volume\":\"37 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-09-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pulmonary embolism\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1183/13993003.congress-2019.pa1460\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pulmonary embolism","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1183/13993003.congress-2019.pa1460","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Anti-Factor Xa levels correlate with recurrent venous thromboembolism and clinically relevant bleeding in patients receiving low-molecular-weight heparin